Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	0	2	4	13	10	8
Market Cap Growth	-85.94%	-52.01%	-70.70%	29.81%	20.98%	-55.46%
Enterprise Value	-7	-5	1	1	0	2
PE Ratio	-	-0.21	-0.42	-1.82	-0.34	-0.64
PS Ratio	0.44	3.86	4.61	17.19	21.72	9.51
PB Ratio	0.04	0.32	1.02	0.95	1.11	0.33
P/FCF Ratio	-0.19	-0.19	-0.41	-1.33	-0.66	-0.74
P/OCF Ratio	-0.19	-0.19	-0.42	-1.39	-0.66	-0.76
EV/Sales Ratio	-10.59	-10.59	1.44	1.11	0.48	2.32
EV/EBITDA Ratio	0.56	0.56	-0.12	-0.11	-0.01	-0.15
EV/EBIT Ratio	0.54	0.54	-0.12	-0.11	-0.01	-0.13
EV/FCF Ratio	0.52	0.52	-0.13	-0.09	-0.01	-0.18
Debt / Equity Ratio	0.10	0.10	0.20	0.07	0.04	0.31
Debt / EBITDA Ratio	-0.06	-0.06	-0.08	-0.14	-0.01	-0.58
Debt / FCF Ratio	-0.06	-0.06	-0.08	-0.10	-0.02	-0.70
Quick Ratio	1.19	1.19	2.02	6.02	2.72	2.57
Current Ratio	1.26	1.26	2.47	6.39	3.10	2.42
Asset Turnover	0.05	0.05	0.08	0.05	0.02	0.03
Interest Coverage	-181.56	-181.56	-159.15	-137.77	-53.45	-121.37
Return on Equity (ROE)	-180.60%	-180.60%	-112.50%	-63.60%	-168.90%	-55.30%
Return on Assets (ROA)	-88.10%	-88.10%	-83.00%	-48.00%	-109.00%	-39.30%
Return on Capital (ROIC)	-155.85%	-155.85%	-235.92%	-62.38%	-330.18%	-44.14%
Earnings Yield	-4224.24%	-481.14%	-237.70%	-54.96%	-297.88%	-157.32%
FCF Yield	-4602.68%	-522.87%	-241.17%	-74.92%	-151.98%	-136.01%
Buyback Yield / Dilution	-8714.17%	-5544.47%	-56.16%	-131.18%	-122.96%	-0.16%
Total Shareholder Return	-8714.17%	-5544.47%	-56.16%	-131.18%	-122.96%	-0.16%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).